Alkylating Drug [EPC]

155181 reported adverse events

Drugs of this class: BUSULFAN TEMOZOLOMIDE MITOMYCIN THIOTEPA IFOSFAMIDE CYCLOPHOSPHAMIDE DACARBAZINE CARMUSTINE CHLORAMBUCIL LOMUSTINE MECHLORETHAMINE HYDROCHLORIDE

These side effects are most commonly reported by patients taking drugs of the Alkylating Drug [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 11419
1 OFF LABEL USE 10063
2 NEUTROPENIA 9347
3 PYREXIA 8666
4 THROMBOCYTOPENIA 6502
5 NAUSEA 6083
6 PRODUCT USE IN UNAPPROVED INDICATION 5973
7 DIARRHOEA 5712
8 PNEUMONIA 5621
9 DRUG INEFFECTIVE 5587
See all common reactions for Alkylating Drug [EPC]

Drugs of the Alkylating Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENGRAFTMENT SYNDROME 247 0.6899
1 CYSTITIS VIRAL 113 0.6384
2 B-CELL TYPE ACUTE LEUKAEMIA 103 0.5852
3 IDIOPATHIC PNEUMONIA SYNDROME 105 0.5676
4 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 956 0.5650
5 ENGRAFT FAILURE 122 0.5648
6 ACUTE GRAFT VERSUS HOST DISEASE 1913 0.5638
7 VENOOCCLUSIVE DISEASE 967 0.5577
8 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 521 0.5572
9 BONE MARROW TRANSPLANT REJECTION 103 0.5450
See all enriched reactions for Alkylating Drug [EPC]